BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Skierucha M, Milne AN, Offerhaus GJA, Polkowski WP, Maciejewski R, Sitarz R. Molecular alterations in gastric cancer with special reference to the early-onset subtype. World J Gastroenterol 2016; 22(8): 2460-2474 [PMID: 26937134 DOI: 10.3748/wjg.v22.i8.2460] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 George S, Lucero Y, Torres JP, Lagomarcino AJ, O'Ryan M. Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children. Front Microbiol 2020;11:90. [PMID: 32117120 DOI: 10.3389/fmicb.2020.00090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
2 Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 2018;10:239-48. [PMID: 29445300 DOI: 10.2147/CMAR.S149619] [Cited by in Crossref: 339] [Cited by in F6Publishing: 218] [Article Influence: 84.8] [Reference Citation Analysis]
3 Din SRU, Nisar MA, Ramzan MN, Saleem MZ, Ghayas H, Ahmad B, Batool S, Kifayat K, Guo X, Huang M, Zhong M. Latcripin-7A from Lentinula edodes C91-3 induces apoptosis, autophagy, and cell cycle arrest at G1 phase in human gastric cancer cells via inhibiting PI3K/Akt/mTOR signaling. Eur J Pharmacol 2021;907:174305. [PMID: 34224698 DOI: 10.1016/j.ejphar.2021.174305] [Reference Citation Analysis]
4 Bure IV, Nemtsova MV. Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected. Int J Mol Sci 2021;22:5683. [PMID: 34073603 DOI: 10.3390/ijms22115683] [Reference Citation Analysis]
5 Delshad E, Shafiee M, Maghsoudi H, Shamsabadi F, Bahramian S. Identification of novel miRNAs with potential role in Gastric Cancer diagnosis: In silico procedure. Meta Gene 2019;19:246-52. [DOI: 10.1016/j.mgene.2018.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Khan A, Ituarte PHG, Raoof M, Melstrom L, Li H, Yuan YC, Lai L, Benjamin Paz I, Goel A, Fong Y, Woo Y. Disparate and Alarming Impact of Gastrointestinal Cancers in Young Adult Patients. Ann Surg Oncol 2021;28:785-96. [PMID: 32740736 DOI: 10.1245/s10434-020-08969-7] [Reference Citation Analysis]
7 Fonseca Cabral G, Azevedo Dos Santos Pinheiro J, Vidal AF, Santos S, Ribeiro-Dos-Santos Â. piRNAs in Gastric Cancer: A New Approach Towards Translational Research. Int J Mol Sci 2020;21:E2126. [PMID: 32204558 DOI: 10.3390/ijms21062126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
8 Bilgiç F, Gerçeker E, Boyacıoğlu SÖ, Kasap E, Demirci U, Yıldırım H, Baykan AR, Yüceyar H. Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk. Turk J Gastroenterol 2018;29:427-35. [PMID: 30249557 DOI: 10.5152/tjg.2018.17350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nguyen NT, Dang NT, Dang QH, Tran VC, Vo HL, Yamaguchi M, Ta TV. Polymorphism of MUC1 Gene in Vietnamese Gastric Cancer Patients: A Multicenter Case-Control Study. Front Oncol 2021;11:694977. [PMID: 34532288 DOI: 10.3389/fonc.2021.694977] [Reference Citation Analysis]
10 Sugai T, Uesugi N, Habano W, Sugimoto R, Eizuka M, Fujita Y, Osakabe M, Toya Y, Suzuki H, Matsumoto T. The clinicopathological and molecular features of sporadic gastric foveolar type neoplasia. Virchows Arch 2020;477:835-44. [PMID: 32533343 DOI: 10.1007/s00428-020-02846-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Szlendak M, Sitarz R, Berbecka M, Mielko J, Morsink F, Maciejewski R, Offerhaus GJA, Polkowski WP. Expression of cyclooxygenase-2 and mucin 1 in colorectal cancer. Mol Clin Oncol 2020;13:52. [PMID: 32874582 DOI: 10.3892/mco.2020.2122] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Hou JY, Wang YG, Ma SJ, Yang BY, Li QP. Identification of a prognostic 5-Gene expression signature for gastric cancer. J Cancer Res Clin Oncol 2017;143:619-29. [PMID: 28035468 DOI: 10.1007/s00432-016-2324-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
13 Zhang WL, Zhu ZL, Huang MC, Tang YJ, Tang YL, Liang XH. Susceptibility of Multiple Primary Cancers in Patients With Head and Neck Cancer: Nature or Nurture? Front Oncol 2019;9:1275. [PMID: 31824853 DOI: 10.3389/fonc.2019.01275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Machlowska J, Pucułek M, Sitarz M, Terlecki P, Maciejewski R, Sitarz R. State of the art for gastric signet ring cell carcinoma: from classification, prognosis, and genomic characteristics to specified treatments. Cancer Manag Res 2019;11:2151-61. [PMID: 30936747 DOI: 10.2147/CMAR.S188622] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
15 Holowatyj AN, Ulrich CM, Lewis MA. Racial/Ethnic Patterns of Young-Onset Noncardia Gastric Cancer. Cancer Prev Res (Phila) 2019;12:771-80. [PMID: 31420363 DOI: 10.1158/1940-6207.CAPR-19-0200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
16 Machlowska J, Kapusta P, Szlendak M, Bogdali A, Morsink F, Wołkow P, Maciejewski R, Offerhaus GJA, Sitarz R. Status of CHEK2 and p53 in patients with early-onset and conventional gastric cancer. Oncol Lett 2021;21:348. [PMID: 33747205 DOI: 10.3892/ol.2021.12609] [Reference Citation Analysis]
17 Chivu-Economescu M, Matei L, Necula LG, Dragu DL, Bleotu C, Diaconu CC. New therapeutic options opened by the molecular classification of gastric cancer. World J Gastroenterol 2018; 24(18): 1942-1961 [PMID: 29760539 DOI: 10.3748/wjg.v24.i18.1942] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
18 Li G, Zhang Z, Chen Z, Liu B, Wu H. LncRNA DLEU2 is activated by STAT1 and induces gastric cancer development via targeting miR-23b-3p/NOTCH2 axis and Notch signaling pathway. Life Sci 2021;277:119419. [PMID: 33785336 DOI: 10.1016/j.lfs.2021.119419] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Nemtsova MV, Kalinkin AI, Kuznetsova EB, Bure IV, Alekseeva EA, Bykov II, Khorobrykh TV, Mikhaylenko DS, Tanas AS, Kutsev SI, Zaletaev DV, Strelnikov VV. Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing. Sci Rep 2020;10:504. [PMID: 31949278 DOI: 10.1038/s41598-020-57544-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
20 Ma X, Feng J, Lu M, Tang W, Han J, Luo X, Zhao Q, Yang L. microRNA-501-5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1. J Cell Biochem 2020;121:1911-22. [PMID: 31746031 DOI: 10.1002/jcb.29426] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
21 Cisło M, Filip AA, Arnold Offerhaus GJ, Ciseł B, Rawicz-Pruszyński K, Skierucha M, Polkowski WP. Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology. Oncotarget 2018;9:19427-42. [PMID: 29721214 DOI: 10.18632/oncotarget.24827] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
22 Bergquist JR, Leiting JL, Habermann EB, Cleary SP, Kendrick ML, Smoot RL, Nagorney DM, Truty MJ, Grotz TE. Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features. Surgery 2019;166:547-55. [PMID: 31331685 DOI: 10.1016/j.surg.2019.04.036] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
23 Song J, Guan Z, Li M, Sha S, Song C, Gao Z, Zhao Y. MicroRNA-154 Inhibits the Growth and Invasion of Gastric Cancer Cells by Targeting DIXDC1/WNT Signaling. Oncol Res 2018;26:847-56. [PMID: 28800791 DOI: 10.3727/096504017X15016337254632] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
24 Pucułek M, Machlowska J, Wierzbicki R, Baj J, Maciejewski R, Sitarz R. Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype. Oncotarget 2018;9:31146-62. [PMID: 30123433 DOI: 10.18632/oncotarget.25757] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
25 Zhang XY, Zhang PY. Gastric cancer: somatic genetics as a guide to therapy. J Med Genet. 2016; Sep 8. [Epub ahead of print]. [PMID: 27609016 DOI: 10.1136/jmedgenet-2016-104171] [Cited by in Crossref: 29] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
26 Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int J Mol Sci. 2020;21. [PMID: 32512697 DOI: 10.3390/ijms21114012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 18.5] [Reference Citation Analysis]
27 Nakamura S, Kanda M, Kodera Y. Incorporating molecular biomarkers into clinical practice for gastric cancer. Expert Rev Anticancer Ther 2019;19:757-71. [PMID: 31437076 DOI: 10.1080/14737140.2019.1659136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]